Thomas Tam Hoang

3PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 14, 2024
Outcomes of a mandatory non-medical switch of infliximab to a biosimilar for inflammatory bowel disease in British Columbia, Canada.

Thomas Tam Hoang, Jacqueline Reid, Cherry Galorport

|Feb 05, 2024
An Update on Anti-TNF Biosimilar Switching-Real-World Clinical Effectiveness and Safety.

Susanna Meade, Elizabeth Squirell, Thomas Tam Hoang

Pageof 1